메뉴 건너뛰기




Volumn 102, Issue 7, 2008, Pages 1055-1064

Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients

Author keywords

Asthma; Fluticasone propionate; Salmeterol; Theophylline

Indexed keywords

FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; THEOPHYLLINE;

EID: 44749085860     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.01.021     Document Type: Article
Times cited : (18)

References (26)
  • 1
    • 0036559945 scopus 로고    scopus 로고
    • Asthma insights & reality in Japan (AIRJ)
    • Adachi M., Morikawa A., and Ishihara K. Asthma insights & reality in Japan (AIRJ). Jpn J Allergol 51 (2002) 411-420
    • (2002) Jpn J Allergol , vol.51 , pp. 411-420
    • Adachi, M.1    Morikawa, A.2    Ishihara, K.3
  • 2
    • 44749087847 scopus 로고    scopus 로고
    • Global Initiative for Asthma. GINA workshop report, global strategy for asthma management and prevention, 2005. 〈http://www.ginasthma.com〉.
    • Global Initiative for Asthma. GINA workshop report, global strategy for asthma management and prevention, 2005. 〈http://www.ginasthma.com〉.
  • 3
    • 0028264310 scopus 로고    scopus 로고
    • Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-24.
    • Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-24.
  • 4
    • 0029880013 scopus 로고    scopus 로고
    • Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
    • Woolcock A., Lundback B., Ringdal N., and Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153 (1996) 1481-1488
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 1481-1488
    • Woolcock, A.1    Lundback, B.2    Ringdal, N.3    Jacques, L.A.4
  • 5
    • 0032906413 scopus 로고    scopus 로고
    • The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group
    • Condemi J.J., Goldstein S., Kalberg C., Yancey S., Emmett A., and Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group. Ann Allergy Asthma Immunol 82 (1999) 383-389
    • (1999) Ann Allergy Asthma Immunol , vol.82 , pp. 383-389
    • Condemi, J.J.1    Goldstein, S.2    Kalberg, C.3    Yancey, S.4    Emmett, A.5    Rickard, K.6
  • 6
    • 0033403842 scopus 로고    scopus 로고
    • Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma
    • Aubier M., Pieters W.R., Schlosser N.J., and Steinmetz K.O. Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 93 (1999) 876-884
    • (1999) Respir Med , vol.93 , pp. 876-884
    • Aubier, M.1    Pieters, W.R.2    Schlosser, N.J.3    Steinmetz, K.O.4
  • 7
    • 0034099011 scopus 로고    scopus 로고
    • Combined salmeterol 50 μg and fluticasone propionate 250 μg in the diskus device for the treatment of asthma
    • Shapiro G., Lumry W., Wolfe J., et al. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 161 (2000) 527-534
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 527-534
    • Shapiro, G.1    Lumry, W.2    Wolfe, J.3
  • 8
    • 0033910893 scopus 로고    scopus 로고
    • Salmeterol/fluticasone propionate combination therapy 50/250 μg twice daily is more effective than budesonide 800 μg twice daily in treating moderate to severe asthma
    • Jenkins C., Woolcock A.J., Saarelainen P., Lundback B., and James M.H. Salmeterol/fluticasone propionate combination therapy 50/250 μg twice daily is more effective than budesonide 800 μg twice daily in treating moderate to severe asthma. Respir Med 94 (2000) 715-723
    • (2000) Respir Med , vol.94 , pp. 715-723
    • Jenkins, C.1    Woolcock, A.J.2    Saarelainen, P.3    Lundback, B.4    James, M.H.5
  • 9
    • 0037406502 scopus 로고    scopus 로고
    • Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma
    • Ind P.W., Dal Negro R., Colman N.C., Fletcher C.P., Browning D., and James M.H. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respir Med 97 (2003) 555-562
    • (2003) Respir Med , vol.97 , pp. 555-562
    • Ind, P.W.1    Dal Negro, R.2    Colman, N.C.3    Fletcher, C.P.4    Browning, D.5    James, M.H.6
  • 10
    • 0942298705 scopus 로고    scopus 로고
    • Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma
    • Bergmann K.C., Lindemann L., Braun R., and Steinkamp G. Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma. Swiss Med Wkly 134 (2004) 50-58
    • (2004) Swiss Med Wkly , vol.134 , pp. 50-58
    • Bergmann, K.C.1    Lindemann, L.2    Braun, R.3    Steinkamp, G.4
  • 11
    • 0031881261 scopus 로고    scopus 로고
    • The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies
    • Davies B., Brooks G., and Devoy M. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies. Respir Med 92 (1998) 256-263
    • (1998) Respir Med , vol.92 , pp. 256-263
    • Davies, B.1    Brooks, G.2    Devoy, M.3
  • 12
    • 0034538067 scopus 로고    scopus 로고
    • Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
    • Nelson H.S., Busse W.W., Kerwin E., et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 106 (2000) 1088-1095
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 1088-1095
    • Nelson, H.S.1    Busse, W.W.2    Kerwin, E.3
  • 13
    • 0037372118 scopus 로고    scopus 로고
    • The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
    • Ringdal N., Eliraz A., Pruzinec R., et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 97 (2003) 234-241
    • (2003) Respir Med , vol.97 , pp. 234-241
    • Ringdal, N.1    Eliraz, A.2    Pruzinec, R.3
  • 14
    • 0028040895 scopus 로고
    • The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease
    • Fjellbirkeland L., Gulsvik A., and Palmer J.B.D. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease. Respir Med 88 (1994) 599-607
    • (1994) Respir Med , vol.88 , pp. 599-607
    • Fjellbirkeland, L.1    Gulsvik, A.2    Palmer, J.B.D.3
  • 15
    • 1942520223 scopus 로고    scopus 로고
    • Efficacy and safety of methylxanthines in the treatment of asthma
    • Sohei M., Makoto F., and Naoto F. Efficacy and safety of methylxanthines in the treatment of asthma. Allergol Int 53 (2004) 13-22
    • (2004) Allergol Int , vol.53 , pp. 13-22
    • Sohei, M.1    Makoto, F.2    Naoto, F.3
  • 16
    • 0027392992 scopus 로고
    • Theophylline. Current thoughts on the risks and benefits of its use in asthma
    • Nasser S.S., and Rees P.J. Theophylline. Current thoughts on the risks and benefits of its use in asthma. Drug Saf 8 (1993) 12-18
    • (1993) Drug Saf , vol.8 , pp. 12-18
    • Nasser, S.S.1    Rees, P.J.2
  • 17
    • 0025217643 scopus 로고
    • Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications
    • Johnston I.D. Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications. BMJ 300 (1990) 929-931
    • (1990) BMJ , vol.300 , pp. 929-931
    • Johnston, I.D.1
  • 18
    • 0033915506 scopus 로고    scopus 로고
    • Theophylline pharmacokinetics with concomitant steroid and gold therapy
    • Falcao A.C., Rocha M.J., Almeida A.M., and Caramona M.M. Theophylline pharmacokinetics with concomitant steroid and gold therapy. J Clin Pharm Ther 25 (2000) 191-195
    • (2000) J Clin Pharm Ther , vol.25 , pp. 191-195
    • Falcao, A.C.1    Rocha, M.J.2    Almeida, A.M.3    Caramona, M.M.4
  • 19
    • 33846051559 scopus 로고    scopus 로고
    • A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD
    • Makino S., Adachi M., Ohta K., et al. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. Allergol Int 55 (2006) 395-402
    • (2006) Allergol Int , vol.55 , pp. 395-402
    • Makino, S.1    Adachi, M.2    Ohta, K.3
  • 20
    • 35448975251 scopus 로고    scopus 로고
    • Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics
    • Kawai M., Kempsfordb R., Pulleritsc T., et al. Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics. Respir Med 101 (2007) 2488-2494
    • (2007) Respir Med , vol.101 , pp. 2488-2494
    • Kawai, M.1    Kempsfordb, R.2    Pulleritsc, T.3
  • 21
    • 44749087794 scopus 로고    scopus 로고
    • ® in Japanese and Caucasian asthma patients [Abstract]. Presented at the 4th world asthma meeting, Bangkok, Thailand, 2004.
    • ® in Japanese and Caucasian asthma patients [Abstract]. Presented at the 4th world asthma meeting, Bangkok, Thailand, 2004.
  • 22
    • 0029763030 scopus 로고    scopus 로고
    • Bioavailability of a new sustained-release anhydrous theophylline product
    • Tatsis G., Tsoukalas G., Haviaras A., et al. Bioavailability of a new sustained-release anhydrous theophylline product. J Int Med Res 24 (1996) 331-339
    • (1996) J Int Med Res , vol.24 , pp. 331-339
    • Tatsis, G.1    Tsoukalas, G.2    Haviaras, A.3
  • 24
    • 0041843809 scopus 로고    scopus 로고
    • Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhaler
    • Sheth K., Bernstein J.A., Lincourt W.R., et al. Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhaler. Ann Allergy Asthma Immunol 91 (2003) 55-60
    • (2003) Ann Allergy Asthma Immunol , vol.91 , pp. 55-60
    • Sheth, K.1    Bernstein, J.A.2    Lincourt, W.R.3
  • 25
    • 23844483910 scopus 로고    scopus 로고
    • Inhaled salmetrol/fluticasone propionate: a review of its use in asthma
    • Reynold N.A., Lyseng-Williamson K.A., and Wiseman L.R. Inhaled salmetrol/fluticasone propionate: a review of its use in asthma. Drugs 65 (2005) 1715-1734
    • (2005) Drugs , vol.65 , pp. 1715-1734
    • Reynold, N.A.1    Lyseng-Williamson, K.A.2    Wiseman, L.R.3
  • 26
    • 0141749461 scopus 로고    scopus 로고
    • Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma
    • Lyseng-Williamson K.A., and Plosker G.L. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma. Pharmacoeconomics 21 (2003) 951-989
    • (2003) Pharmacoeconomics , vol.21 , pp. 951-989
    • Lyseng-Williamson, K.A.1    Plosker, G.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.